Seeking approval, MannKind stock jumps on FDA approval MannKind Corporation (NASDAQ: MNKD) shares rose 6% Friday morning after the company announced FDA approval of Furoscix ReadyFlow and a $50 million private placement.The FDA approved Furoscix ReadyFlow (furosemide...
Life after Kroger fallout, Albertsons tumbles on earnings miss and slashed guidance Albertsons Companies, Inc. (NYSE: ACI) reported first-quarter results that missed analyst expectations and significantly reduced its full-year outlook, citing pressure from softer...
How do you like your stake, Google reports $94 billion stake in SpaceX In an SEC filing today, Google parent company Alphabet officially revealed the staggering magnitude of its decade-long bet on SpaceX following the rocket manufacturer’s record-breaking public...
Almost to the finish line, Arrowhead Pharmaceuticals stock jumps on Phase 3 trial results Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares rose 18% Wednesday following the announcement of topline results from its Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran...
All phases, Summit Therapeutics stock rises on positive cancer trial data Summit Therapeutics Inc. (NASDAQ: SMMT) rose 3% Wednesday following the release of updated overall survival results from its global Phase III HARMONi clinical trial evaluating ivonescimab plus...
